In the 10 years since the drugmaker Gilead debuted a revolutionary treatment for hepatitis C, a wave of new therapies have been used to cure millions of people around the world of the blood-borne virus.
Today, 15 countries, including Egypt, Canada, and Australia, are on track to eliminate hepatitis C during this decade, but the arsenal of drugs has not brought the United States any closer to eradicating the disease.
Only a fraction of Americans with the virus are aware of the infection, with many developing the fatal disease, but those most at risk have difficulty navigating the American health system for treatment.
Of those diagnosed in the United States since 2013, just 34 percent have been cured, highlighting challenges faced by vulnerable populations like those incarcerated, uninsured, or homeless.
[
add
]
[
|
|
...
]